Clinical Trial: Patent Foramen Ovale in Cryptogenic Stroke Study

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Patent Foramen Ovale in Cryptogenic Stroke Study

Brief Summary: The study sought to assess the rate of recurrent stroke and death in stroke patients with a patent foramen ovale randomized to treatment with warfarin or aspirin. This was a multicenter study conducted at 48 U.S. Institutions.

Detailed Summary:
Sponsor: Columbia University

Current Primary Outcome: Recurrent ischemic stroke and death [ Time Frame: 2 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Columbia University

Dates:
Date Received: June 11, 2008
Date Started: June 1993
Date Completion:
Last Updated: September 14, 2011
Last Verified: September 2011